Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tazobactam × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Sarcoma 1 Plasma cell 1 Myeloid 1 Lymphoid 1 Dermatologic 1 Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 85 fludarabine phosphate 76 Busulfan 54 Cyclosporine 52 Whole-Body Irradiation 49 Epoetin Alfa 49 Mycophenolic Acid 48 Peripheral Blood Stem Cell Transplantation 44 fludarabine 38 Cytarabine 37 Melphalan 35 Antilymphocyte Serum 35 Filgrastim 34 Darbepoetin alfa 34 Tacrolimus 33 Methotrexate 29 Radiotherapy 27 Cord Blood Stem Cell Transplantation 26 Granulocyte Colony-Stimulating Factor 20 Etoposide 20 Methylprednisolone 18 eltrombopag 15 apixaban 15 Dalteparin 15 ferric carboxymaltose 14 Azacitidine 14 Alemtuzumab 14 Thiotepa 13 Rivaroxaban 13 thymoglobulin 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡